RF IgG Test

Rheumatoid factor IgG is an autoantibody, meaning an antibody made by the immune system that mistakenly targets the body’s own proteins. In this case, it binds to the Fc portion of IgG antibodies. The Fc portion is the tail region of an antibody that normally helps recruit immune cells and activate complement, which is a protein system that amplifies inflammation. When antibodies target this region, they can form immune complexes, which are clusters of antibodies bound together. These complexes can circulate or deposit in tissues and trigger inflammation.

Rheumatoid factor exists in several antibody classes, also called isotypes. These include IgM, IgA, and IgG. IgM rheumatoid factor is the most common and is the version most people are familiar with. IgA rheumatoid factor is less common but often linked to mucosal immune activity, such as inflammation involving the lungs or gut. IgG rheumatoid factor is the least common of the three in rheumatoid arthritis and is detected in a smaller subset of patients.

From a biological perspective, IgG rheumatoid factor appears later in the autoimmune process. Long before joint symptoms begin, the immune system may start producing IgM rheumatoid factor, followed by IgA. IgG rheumatoid factor often emerges closer to the onset of clinical disease. This timing suggests it reflects a more mature and expanded autoimmune response rather than early immune dysregulation.

Clinically, rheumatoid factor IgG has lower sensitivity than other rheumatoid factor isotypes. Sensitivity refers to how often a test is positive when a disease is truly present. Because IgG rheumatoid factor is found in only a minority of people with rheumatoid arthritis, a normal result does not rule out disease. That said, it has relatively higher specificity. Specificity describes how likely a positive result truly reflects the disease rather than another condition. When IgG rheumatoid factor is present, it is more suggestive of autoimmune pathology than IgM alone.

Like other rheumatoid factor isotypes, IgG rheumatoid factor is not exclusive to rheumatoid arthritis. It can appear in other autoimmune diseases such as Sjögren’s syndrome, as well as in chronic infections and inflammatory states. For this reason, results must always be interpreted in context with symptoms, imaging, and other biomarkers such as anti citrullinated protein antibodies, often called anti CCP or ACPA. These antibodies target proteins that have undergone citrullination, a chemical modification that can occur during inflammation, and they are more specific for rheumatoid arthritis than rheumatoid factor of any isotype.

In modern clinical practice, IgG rheumatoid factor is rarely ordered on its own. Most laboratories report total rheumatoid factor or IgM rheumatoid factor, sometimes alongside IgA. IgG measurement is mainly useful in research settings or in specialized evaluations where clinicians are assessing the full autoimmune antibody profile. For most patients, it adds limited additional information beyond standard rheumatoid factor and anti CCP testing.